199 related articles for article (PubMed ID: 30360480)
21. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H
Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014
[TBL] [Abstract][Full Text] [Related]
22. Dissociation in response to methylphenidate on response variability in a group of medication naïve children with ADHD.
Johnson KA; Barry E; Bellgrove MA; Cox M; Kelly SP; Dáibhis A; Daly M; Keavey M; Watchorn A; Fitzgerald M; McNicholas F; Kirley A; Robertson IH; Gill M
Neuropsychologia; 2008 Apr; 46(5):1532-41. PubMed ID: 18289615
[TBL] [Abstract][Full Text] [Related]
23. OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.
Ramos-Quiroga JA; Corominas M; Castells X; Bosch R; Casas M
Expert Rev Neurother; 2009 Aug; 9(8):1121-31. PubMed ID: 19673602
[TBL] [Abstract][Full Text] [Related]
24. A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study.
Hegvik TA; Jacobsen KK; Fredriksen M; Zayats T; Haavik J
J Neural Transm (Vienna); 2016 Aug; 123(8):859-65. PubMed ID: 27091191
[TBL] [Abstract][Full Text] [Related]
25. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.
Levin FR; Evans SM; Brooks DJ; Garawi F
Drug Alcohol Depend; 2007 Feb; 87(1):20-9. PubMed ID: 16930863
[TBL] [Abstract][Full Text] [Related]
26. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.
Biederman J; Mick E; Surman C; Doyle R; Hammerness P; Harpold T; Dunkel S; Dougherty M; Aleardi M; Spencer T
Biol Psychiatry; 2006 May; 59(9):829-35. PubMed ID: 16373066
[TBL] [Abstract][Full Text] [Related]
27. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
[TBL] [Abstract][Full Text] [Related]
28. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.
Rhodes SM; Coghill DR; Matthews K
J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758
[TBL] [Abstract][Full Text] [Related]
29. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Epstein T; Patsopoulos NA; Weiser M
Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
[TBL] [Abstract][Full Text] [Related]
30. Prediction of methylphenidate treatment outcome in adults with attention-deficit/hyperactivity disorder (ADHD).
Retz W; Retz-Junginger P
Eur Arch Psychiatry Clin Neurosci; 2014 Nov; 264 Suppl 1():S35-43. PubMed ID: 25231833
[TBL] [Abstract][Full Text] [Related]
31. Effects of Atomoxetine and Osmotic Release Oral System-Methylphenidate on Executive Functions in Patients with Combined Type Attention-Deficit/Hyperactivity Disorder.
Ince Tasdelen B; Karakaya E; Oztop DB
J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):494-500. PubMed ID: 26218871
[TBL] [Abstract][Full Text] [Related]
32. Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.
Kim BN; Kim JW; Cummins TD; Bellgrove MA; Hawi Z; Hong SB; Yang YH; Kim HJ; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH
J Clin Psychopharmacol; 2013 Jun; 33(3):356-62. PubMed ID: 23609393
[TBL] [Abstract][Full Text] [Related]
33. [Response With Methylphenidate to ADHD-Like Symptoms in Pervasive Developmental Disorder: Does CES-1 Enzyme Gene Polymorphism Have a Role?].
Akyol Ardıç Ü; Ercan ES; Aygüneş D; Yüce D; Durak S; Kosova B
Turk Psikiyatri Derg; 2017; 28(2):89-94. PubMed ID: 29192941
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study.
Wigal SB; Nordbrock E; Adjei AL; Childress A; Kupper RJ; Greenhill L
CNS Drugs; 2015 Apr; 29(4):331-40. PubMed ID: 25877989
[TBL] [Abstract][Full Text] [Related]
35. Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder.
Tucha O; Prell S; Mecklinger L; Bormann-Kischkel C; Kübber S; Linder M; Walitza S; Lange KW
Psychopharmacology (Berl); 2006 Apr; 185(3):315-26. PubMed ID: 16521033
[TBL] [Abstract][Full Text] [Related]
36. Effects of long-acting methylphenidate in adults with attention deficit hyperactivity disorder: a study with paired-pulse transcranial magnetic stimulation.
Schneider MK; Retz W; Gougleris G; Verhoeven WM; Tulen JH; Rösler M
Neuropsychobiology; 2011; 64(4):195-201. PubMed ID: 21912187
[TBL] [Abstract][Full Text] [Related]
37. Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.
Kim H; Heo HI; Kim DH; Ko IG; Lee SS; Kim SE; Kim BK; Kim TW; Ji ES; Kim JD; Shin MS; Choi YW; Kim CJ
Neurosci Lett; 2011 Oct; 504(1):35-9. PubMed ID: 21907264
[TBL] [Abstract][Full Text] [Related]
38. Association of the GRIN2B rs2284411 polymorphism with methylphenidate response in attention-deficit/hyperactivity disorder.
Kim JI; Kim JW; Park JE; Park S; Hong SB; Han DH; Cheong JH; Choi JW; Lee S; Kim BN
J Psychopharmacol; 2017 Aug; 31(8):1070-1077. PubMed ID: 27624150
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of atomoxetine and methylphenidate for problematic online gaming in adolescents with attention deficit hyperactivity disorder.
Park JH; Lee YS; Sohn JH; Han DH
Hum Psychopharmacol; 2016 Nov; 31(6):427-432. PubMed ID: 27859666
[TBL] [Abstract][Full Text] [Related]
40. Manganese in children with attention-deficit/hyperactivity disorder: relationship with methylphenidate exposure.
Farias AC; Cunha A; Benko CR; McCracken JT; Costa MT; Farias LG; Cordeiro ML
J Child Adolesc Psychopharmacol; 2010 Apr; 20(2):113-8. PubMed ID: 20415606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
